Compare Credo Technology Group Holding Ltd (CRDO) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Credo Technology Group Holding Ltd vs Dolby Laboratories, Inc. — how do they compare? Credo Technology Group Holding Ltd trades at $216.89 (market cap $41.35B), while Dolby Laboratories, Inc. trades at $58.47 (market cap $5.47B). The key difference: Credo Technology Group Holding Ltd is far larger — about 7.6× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.47% dividend while Credo Technology Group Holding Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Credo Technology Group Holding Ltd for 22 Days and Dolby Laboratories, Inc. for 98 Days on average.
| CRDO | DLB | |
|---|---|---|
Market Cap | $41.35B | $5.47B |
Volume | 7,290,508 | 691,016 |
Sector | Technology | Technology |
52-Week High | $302.52 | $70.09 |
52-Week Low | $87.81 | $48.51 |
Typical Hold Time | 22 Days | 98 Days |
Enterprise Value | $40.61B | $4.84B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRDO trades at $220.01, down 0.37% on the day, with strong technical momentum indicated by bullish moving averages and key support at $213. The company demonstrates exceptional fundamental strength with 114.7% YoY revenue growth in Q2 2026 and a 33.83% net income margin. Recent news highlights Credo's positioning as a key beneficiary of AI infrastructure spending, with triple-digit revenue growth driven by high-speed connectivity solutions for data centers.
Outlook remains positive with 87.5% analyst buy ratings and a $267.33 consensus price target representing 21.5% upside. Key risks include premium valuation multiples (P/E 77.47) and customer concentration, while growth catalysts center on AI-driven demand and expanding optical product offerings. The stock's recent 20.3% monthly decline may present a buying opportunity given strong fundamentals.
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.
DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Credo Technology Group Holding Ltd
Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
